TP53 and cancer: Furthermore, recent reports suggest that mutant p53, by interfering with the cytoplasmic DNA sensing machinery cGAS-STING-TBK1-IRF3, disrupts both cell-autonomous and non-cell-autonomous signaling, promoting cancer cell survival and evading tumor immune surveillance (Ghosh et al., 2021).